云南白药

- 000538

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
云南白药(000538) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入2,968,853.212,030,937.291,051,275.103,648,837.262,691,568.97
营业收入2,968,853.212,030,937.291,051,275.103,648,837.262,691,568.97
二、营业总成本2,565,534.641,746,256.68907,960.233,208,716.822,309,681.31
营业成本2,156,176.681,471,323.23763,014.262,688,348.531,932,179.63
营业税金及附加15,667.9810,837.284,790.5821,048.9415,463.86
销售费用335,409.25225,768.85120,076.17416,556.39308,901.12
管理费用55,544.7134,444.3816,447.5083,378.4353,534.70
财务费用-19,124.58-10,599.06-2,776.87-34,287.84-21,184.29
研发费用21,860.6014,481.996,408.5933,672.3720,786.28
资产减值损失----------
公允价值变动收益10,364.715,308.8910,315.21-61,990.29-75,171.45
投资收益70,322.3542,154.2224,239.9086,819.8471,983.50
其中:对联营企业和合营企业的投资收益64,856.7044,704.8926,721.0773,223.3360,387.36
汇兑收益----------
三、营业利润487,337.72331,334.54173,018.07337,127.92253,685.20
加:营业外收入567.67200.27263.661,358.92406.56
减:营业外支出1,529.071,206.85566.42786.59419.59
其中:非流动资产处置损失----------
四、利润总额486,376.33330,327.97172,715.31337,700.24253,672.17
减:所得税费用74,125.7347,702.0821,142.9653,659.2739,648.84
五、净利润412,250.60282,625.88151,572.35284,040.97214,023.33
归属于母公司所有者的净利润412,347.74282,801.16151,798.84300,112.59230,489.63
少数股东损益-97.14-175.28-226.49-16,071.62-16,466.30
六、每股收益
基本每股收益(元/股)2.31001.58000.85001.90001.5300
稀释每股收益(元/股)2.30001.58000.85001.90001.5200
七、其他综合收益-2,775.64-2,874.94656.16-8,141.24-9,924.13
八、综合收益总额409,474.96279,750.94152,228.51275,899.73204,099.20
归属于母公司所有者的综合收益总额409,140.02280,047.43152,277.41293,052.44221,524.19
归属于少数股东的综合收益总额334.94-296.49-48.91-17,152.72-17,425.00
下载全部历史数据到excel中 返回页顶